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Introduction
Multidrug resistance (MDR) is the main clinical 
challenge for the active treatment of cancer (chemotherapy) 
(Szabo and Molnar, 1997). There are numerous 
mechanisms by which tumor cells develop resistance 
to antitumor agents. One of them is produced by the 
overexpression of ATP-binding cassette (ABC) proteins. 
The ABC transporters represent the largest family of 
transmembrane proteins that bind ATP and use the energy 
to drive the transport of various molecules across cell 
membranes (Gottesman and Ambudkar, 2001; Leonard 
et al., 2003). ABC efflux transporters extrude a broad 
range of amphiphilic compounds against the concentration 
gradient in an energy-dependent fashion. Many of the 
ABC transporters have dedicated physiological functions, 
normal tissue protection in the brain, liver and kidney 
(Gottesman et al., 2002; Sarkadi et al., 2006; Szakacs et 
al., 2006).
The first identified drug efflux protein was 
P-glycoprotein (P-gp, ABCB1) encoded by the ABCB1 
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Abstract
 Phytochemical investigation of Pistacia integerrima has highlighted isolation of two known compounds 
naringenin (1) and dihydrokaempferol (2). A crude extract and these isolated compounds were here evaluated 
for their effects on reversion of multidrug resistance (MDR) mediated by P-glycoprotein (P-gp). The multidrug 
resistance P-glycoprotein is a target for chemotherapeutic drugs from cancer cells. In the present study rhodamine- 
123 exclusion screening test on human mdr1 gene transfected mouse gene transfected L5178 and L5178Y mouse 
T-cell lymphoma cells showed excellent MDR reversing effects in a dose dependent manner. In-silico molecular 
docking investigations demonstrated a common binding site for Rhodamine123, and compounds naringenin 
and dihydrokaempferol. Our results showed that the relative docking energies estimated by docking softwares 
were in satisfactory correlation with the experimental activities. Preliminary interaction profile of P-gp docked 
complexes were also analysed in order to understand the nature of binding modes of these compounds. Our 
computational investigation suggested that the compounds interactions with the hydrophobic pocket of P-gp 
are mainly related to the inhibitory activity. Moreover this study s a platform for the discovery of novel natural 
compounds from herbal origin, as inhibitor molecules against the P-glycoprotein for the treatment of cancer. 
Keywords: Pistacia integerrima - naringenin - dihydrokaempferol - multidrug resistance (MDR)
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gene. ABCB1 is composed of 1280 amino acids 
(170 kDa) organized in two transmembrane domains 
(Szakacs et al., 2006). This protein is overexpressed in 
several human tumors, can extrude wide range of drugs 
(anticancer, antibiotics, antidepressants, antihistamines, 
antiarrhythmics, immunosuppressants, HIV protease 
inhibitors, steroids). Many drug molecules such as 
tamoxifen, valspodar, dexniguldipine, tariquidar were 
proposed to suppress the action of ABCB1 (Germann et 
al., 1993; Lopez and Martinez, 2014) . 
Secondly, the Multidrug-Resistant Protein 1 (MRP1, 
ABCC1) was described in 1992. MRP1 is an efflux 
pump originally discovered in doxorubicin resistant 
lung carcinoma cells displaying a multi-drug resistant 
phenotype without ABCB1 expression (Cole et al., 1992). 
MRP1 is expressed ubiquitously at higher level in 
the blood-brain barrier, intestines and oral mucosa (He 
et al., 2011). MRP1 expression is higher in the lung than 
in any other organ and may have protective roles against 
air pollution and inhaled toxins (Sakamoto et al., 2013). 
MRP1 physiological substrates include bile acids, folic 
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acid, leukotriene C4, glutathione conjugates, and confers 
resistance to vincristine, methotrexate, doxorubicin, 
etoposide (Cole and Deeley, 2006). MRP1 expressing 
lung tumors were identified in 31.6% and correlated 
with poor response to cisplatin therapy with vinorelbine, 
gemcitabine and paclitaxel (Li et al., 2008). 
Thirdly, the Breast Cancer Resistance Protein (BCRP) 
was first cloned by standard protocol (Doyle et al., 1998) in 
the drug-resistant breast cancer cell line (MCF-7). BCRP 
is a half-transporter member of the ABCG subfamily 
(ABCG2) with a size of 72 kDa. BCRP probably functions 
as a homodimer. BCRP expression overlaps largely with 
ABCB1, because the protein can be found in tissues like 
placenta, prostate, small intestine, brain, colon, liver, and 
ovary (Doyle et al., 1998). Overexpression of BCRP is 
associated with resistance to a wide range of different 
anticancer agents including anthracyclines, mitoxantrone, 
flavopiridol camptothecins and antifolates (Assaraf, 2006; 
Bihorel et al., 2007; Robey et al., 2007). 
Several studies have demonstrated the frequent 
occurrence of drug efflux proteins in cancer tissue: some 
authors have reported significant correlations between 
overexpression of ABCB1 or MRP-1 and poor treatment 
response in solid tumors and some leukemias (Brinkhuis 
et al., 2002; Diestra et al., 2003) (Larkin et al., 2004; 
Damiani et al., 2006), and a prognostic significance for 
BCRP overexpression in specific forms of leukemia 
(Larkin et al., 2004).
P-gp belongs to the ABC superfamily of transporters. 
Members of this family are broadly spread in the three 
kingdoms and they also play a role in the MDR of 
pathogen yeasts and bacteria against antimicrobials. 
Due to its involvement in the treatment of cancer and 
other human diseases, P-gp is probably the best known 
of the ABC proteins and thus, it can be considered as a 
paradigmatic model for this family of transporters (Jones 
and George, 2004).
It has 1280 amino acids are arranged as a single chain 
with two homologous halves having 43% amino acid 
identity. A linker region of ~60 amino acids connects the 
two halves of the protein. Each half has six transmembrane 
domains (TM) and a hydrophilic domain containing an 
ATP-binding site, known as nucleotide binding domain 
(NBD) (Jara et al., 2013).
The primary binding region for Rhodamine123 
in mouse P-gp was found to be a hydrophobic pocket 
involving binding site residues such as Ser218, Phe299, 
Val334, Leu335, Phe339, which have already been 
proposed to play a crucial role for substrate binding on 
experimental bases (Li et al., 2010).
Pistacia integerrima belongs to family Anacardiacea, 
commonly known as kakar singhi  which is found in 
Eastern Himalayan range from Indus to Kumaon (Ismail et 
al., 2011), at height of 12000 to 8000 feet. P. integerrima 
is a medium sized deciduous tree having medicinal value 
such as anti-inflammatory, blood purifier, and remedy for 
gastrointestinal disorders, expectorant, cough, asthma, 
fever, vomiting and diarrhea according to our former 
studies (Uddin et al., 2011) (Ahmad et al., 2010). The 
galls of P. integerrima are used as herbal drug for the 
treatment asthma, diarrhea, chronic bronchitis, disorders 
of respiratory tract, skin diseases, psoriasis, fever, and as 
appetizer, hepatitis, liver disorders, oxidative stress and 
counter hyperuricemia (Uddin et al., 2012a; Uddin et al., 
2012b).
Reversal of Multidrug Resistance Mouse Lymphoma 
cells activity of the extract and its isolated compound 
has been evaluated which showed remarkable activities. 
Materials and Methods
Assay for reversal of MDR in mouse lymphoma cells
The L5178 MDR and L5178Y parent cell lines were 
grown in McCoy`s 5A medium containing 10% heat-
inactivated horse serum, was completed with L-glutamine 
and antibiotics. The cells were adjusted to a density 
of 2×106 mL resuspended in serum-free McCoy`s 5A 
medium and distributed in 0.5 mL aliquots into Eppendorf 
centrifuge tubes. The tested compound was added at 4 μg/
ml final concentrations, and the samples were incubated 
for 10 minutes at room temperature. Verapamil was 
applied as positive control (Cornwell et al., 1987) in 10 
µg/ml concentration. 
Next, 10 µL (5.2 µM final concentration) of the 
indicator rhodamine 123 (Sigma, St Louis, MO, USA) was 
added to the samples and the cells were incubated for a 
further 20 minutes at 37ºC, washed twice and resuspended 
in 0.5 mL PBS for analysis. The fluorescence of the cell 
population was measured with a Partec CyFlow flow 
cytometer (Münster, Germany). The tested compound 
was dissolved in DMSO, which was also used as solvent 
control. The percentage of mean fluorescence intensity 
was calculated for the treated MDR and parental cell lines 
as compared with the untreated cells. The activity ratio R 
was calculated via the following equation (Cornwell et al., 
1987) on the basis of the measured fluorescence values:
FAR= 
MDRtreated  / MDRcontrol 
parentaltreated  ⁄ parentalcontrol
Extraction and Isolation
The shade dried and crushed barks of P. integerrima (14 
kg) were defatted with petroleum ether and then subjected 
to repeated extraction with methanol at room temperature. 
Then the combined methanol extracts were evaporated 
under reduced pressure with the aid of a rotary evaporator 
to afford 600 g of dried residue. The resulting residue was 
dissolved in distilled water and sequentially separated 
with various organic solvents including n-hexane, 
CHCl3, EtOAc, and n-BuOH. The green residue from 
the chloroform fraction (15.2 g) was chromatographed 
on a silica gel column eluted with chloroform/methanol 
mixtures of increasing polarity (100:0 g95:5, v: v). 
Fractions obtained were collected and grouped according 
to their TLC behavior into 10 different sub-fractions (PS-1 
to PS-10). Fraction PS-10 obtained with 95:05 chloroform/
methanol was subjected to repeated pencil column 
chromatography (100:0 g98:2) to afford a yellowish 
amorphous solid identified as naringenin (1) followed 
by a yellow needle crystalline solid, dihydrokaempferol 
(2). Compounds 1 and 2 were identified by comparing 
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their spectral data (1H and 13C-NMR spectra) with those 
reported in the literature (Bihorel et al., 2007; Robey et 
al., 2007). Further elution of the column with MeOH-
chloroform (0:100 g 3:97) resulted in the isolation of a 
dark yellow powder which according to TLC consisted of 
a mixture of two compounds. This mixture was separated 
into its components by means of preparative TLC to 
yield dihydrokaempferol (3) and dihydrokaempferol 
(4); identities of these compounds were confirmed by 
comparison of their spectral data with those reported
Plant material 
P. integerrima (Anacardiacea) were collected in the 
garden of Sultan Muhammad Razagram, district Dir, 
K.P.K, Pakistan was recognize by Prof. Dr. A. Rashid 
of Botany Department University of Peshawar (UOP), 
Pakistan. A voucher specimen (no, Bot.20037 (PUP) has 
been deposited in said department. 
Computational studies
The 3-D structure of mice P-glycoprotein (P-gp) was 
downloaded from protein data bank (PDB) (Berman et 
al., 2000) with a four letter code of 4Q9L (Resolution 
3.80Å). Energy refinement of the structure was carried out 
through Swiss pdb viewer v4.1.0 program implemented 
with GROMOS96 force field (Guex and Peitsch, 1997). 
Compound flavonoids structures were prepared for 
docking studies through Chem sketch (Li et al., 2004) and 
Avogadro,s software (Hanwell et al., 2012). 
There are two docking softwares i.e Autodock Vina 
(Trott and Olson, 2010) and i-GEMDOCKv 2.1 (Hsu et al., 
2011) was used for docking studies. Method optimizations 
of docking softwares were carried out through co-
crystallized ligand of P-gp. The Autodock Vina was 
operated through PyRex tools (Praveen and Yellamma, 
2014). Moreover all the default parameters were used 
for docking through Autodock Vina. Another docking 
was carried out through i-GEMDOCKv2.1 software. 
Similarly default procedure was used for docking (Rauf 
et al., 2015a; Rauf et al., 2015b; Rauf et al., 2015c). The 
docking analysis was carried out through LIGPLOT+ 
version v.1.4.5 (Wallace et al., 1995) and Discovery studio 
visualizer softwares (Visualizer, 2005).
Results and Discussion
Reversal of Multidrug Resistance in Mouse Lymphoma 
cells
The effect of multidrug resistance in mouse lymphoma 
cells is displayed in Table 1. The crude extract showed 
promising MDR effect, while compounds 1 and 2 was 
found less active. The fluorescence activity ratio (FAR) 
value was used to evaluate the ABCB1 transporter 
modulating potential. Among the tested compounds when 
the compounds were screen in various concentration 
at 4 µg/ml (Table 1). The values of SSC (side scatter 
count) and FSC (forward scatter count) were increased 
in the flowcytometry which showed that the extract and 
compounds (1, 2) had membrane effect and the granulation 
of cytoplasm was increased. The FAR values obtained 
by using extract and its compound (1,2) were different, 
indicating that extract is very effective MDR modulator, 
and compounds 1 and 2 had no significant effect in a short 
time experiment. Verapamil, which is a calcium channel 
blocker and chemosensitizer, was used as a positive 
control. On MDR mouse lymphoma cells the extract was 
screen in two concentrations (4 µg/ml). The extract was 
strong modulators of the efflux-pump activity (FAR 64.02, 
4 µg/ml) while compounds 1 and 2 (FAR 1.58 and 1.79 
at 4 µg/ml) (Table 1).
Computer based drug designing has vital role in 
predicting the inhibiting potency of new compounds 
Table 1. Docking Interaction Energies of Compounds 
(1-2) and Rhodamine 
Compounds Autodock Vina i-GEM DOCK
 B. Affinity Total Energy VDW HBond Elec
1 -7.5 -78 -46 -32 0
2 -7.3 -74 -60 -14 0
Rhodamine123 -8.2 -87 -86 -1 0
Figure 1. The Docking Pattern of Compounds 
(1-2) Shown by Ball And Sticks Green Colour, Co-
crystallized Ligand (Cyan Colour Sticks) while the 
Rhodamine is Shown by Sticks Red Colour Against 
the P-glycoprotein from Mice
Figure 2. The 2-D Interactions Representation of 
Compounds 1(left) and 2(right) against P-glycoprotein. 
In the above Figure Green Dotted Lines Represent 
Hydrogen Bonding with Distance In Angstrom 
while Red Half-moon Represents the Hydrophobic 
Interactions
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against the targeted receptors. Molecular docking studies, 
was performed to recognize the inhibiting potential of 
selected flavonoids (1 and 2) against P-gp from mice. This 
study co-relates the in-vitro results with in-silico studies. 
The selected flavonoids and standard Rhodamine were 
docked into the crystal structure of P-gp. Our docking 
studies reveal that these compounds give satisfactory 
docking result on the both docking softwares. As it is 
cleared from the Figure 1 these compounds not exactly 
bind in the region where already co-crystallized ligand 
is present. Generally docking study predicts that, if 
a compound give lesser interaction energy then that 
compound has higher activity. Our result of the compounds 
interaction energies are near to the Rhodamine (Table 1). 
Hence we can conclude that there are certain structural 
features of selected flavonoids which are responsible for 
the inhibitory activities of P-gp from mice.
The docking interactions of the compound 1 (Figure 
2) revealed that, it forms a total of five hydrogen bonding 
interactions. Including them two hydrogen bond are 
observed from the Gln942 with a distance of 2.85Å and 
2.96Å while other three hydrogen bond are shown by 
the residues Gln191, Thr195 and Ser340 with a distance 
of 2.95Å, 3.02Å and 3.19Å respectively. Only one 
hydrophobic contact is observed from the residue Gln343. 
The compound 2 (Figure 2) binding to the P-gp is 
quite weak, because it form only one hydrogen bond 
interaction with Thr941 with a distance of 2.94Å while 
six hydrophobic contacts have been observed from 
the residues such as Ile864, Ala865, Gly868, Glu871, 
Meth945 and Ala981.
References
Ahmad NS, Waheed A, Farman M, et al (2010). Analgesic and 
anti-inflammatory effects of Pistacia integerrima extracts 
in mice. J Ethnopharmacol, 129, 250-3.
Assaraf YG (2006). The role of multidrug resistance efflux 
transporters in antifolate resistance and folate homeostasis. 
Drug Resistance Updates, 9, 227-46.
Berman HM, Westbrook J, Feng Z, et al (2000). The protein data 
bank. Nucleic Acids Res, 28, 235-42.
Bihorel S, Camenisch G, Lemaire M, et al (2007). Modulation 
of the brain distribution of imatinib and its metabolites in 
mice by valspodar, zosuquidar and elacridar. Pharmaceutical 
Res, 24, 1720-8.
Brinkhuis M, Izquierdo MA, Baak J, et al (2002). Expression 
of multidrug resistance-associated markers, their relation to 
quantitative pathologic tumour characteristics and prognosis 
in advanced ovarian cancer. Analytical Cellular Pathol, 
24, 17-23.
Cole S, Bhardwaj G, Gerlach J, et al (1992). Overexpression of a 
transporter gene in a multidrug-resistant human lung cancer 
cell line. Science-New York Then Washington, 258, 1650-.
Cole SP, Deeley RG (2006). Transport of glutathione and 
glutathione conjugates by MRP1. Trends Pharmacological 
Sci, 27, 438-46.
Cornwell MM, Pastan I, Gottesman MM (1987). Certain calcium 
channel blockers bind specifically to multidrug-resistant 
human KB carcinoma membrane vesicles and inhibit drug 
binding to P-glycoprotein. J Biological Chem, 262, 2166-70.
Damiani D, Tiribelli M, Calistri E, et al (2006). The prognostic 
value of P-glycoprotein (ABCB) and breast cancer resistance 
protein (ABCG2) in adults with de novo acute myeloid 
leukemia with normal karyotype. Haematologica, 91, 825-8.
Diestra JE, Condom E, Del Muro XG, et al (2003). Expression 
of multidrug resistance proteins P-glycoprotein, multidrug 
resistance protein 1, breast cancer resistance protein and 
lung resistance related protein in locally advanced bladder 
cancer treated with neoadjuvant chemotherapy: biological 
and clinical implications. J Urol, 170, 1383-7.
Doyle LA, Yang W, Abruzzo LV, et al (1998). A multidrug 
resistance transporter from human MCF-7 breast cancer 
cells. Proceedings National Acad Sciences, 95, 15665-70.
Germann UA, Pastan I, Gottesman MM (1993). P-glycoproteins: 
mediators of multidrug resistance. Seminars Cell Biol, 4, 
63-76.
Gottesman MM, Ambudkar SV (2001). Overview: ABC 
transporters and human disease. J Bioenergetics 
Biomembranes, 33, 453-8.
Gottesman MM, Fojo T, Bates SE (2002). Multidrug resistance 
in cancer: role of ATP-dependent transporters. Nature Rev 
Cancer, 2, 48-58.
Guex N, Peitsch MC (1997). SWISS-MODEL and the Swiss-Pdb 
Viewer: an environment for comparative protein modeling. 
Electrophoresis, 18, 2714-23.
Hanwell MD, Curtis DE, Lonie DC, et al (2012). Avogadro: 
An advanced semantic chemical editor, visualization, and 
analysis platform. J. Cheminformatics, 4, 17.
He S-M, Li R, R Kanwar J, et al (2011). Structural and functional 
properties of human multidrug resistance protein 1 (MRP1/
ABCC1). Current medicinal chemistry, 18, 439-81.
Hsu KC, Chen YF, Lin SR, et al (2011). iGEMDOCK: a 
graphical environment of enhancing GEMDOCK using 
pharmacological interactions and post-screening analysis. 
BMC Bioinformatics, 12, 33.
Ismail M, Muhammad N, Mohani N, et al (2011). Pharmacognostic 
and phytochemical investigation of the stem bark of Pistacia 
integerrima Stew ex Brandis. J Med Plants Res, 5, 3891-5.
Jara GE, Vera DMA, Pierini AB (2013). Binding of modulators 
to mouse and human multidrug resistance P-glycoprotein. 
A computational study. J Molecular Graphics Modelling, 
46, 10-21.
Jones P, George A (2004). The ABC transporter structure and 
mechanism: perspectives on recent research. Cellular 
Molecular Life Sciences CMLS, 61, 682-99.
Larkin A, O’Driscoll L, Kennedy S, et al (2004). Investigation 
of MRP-1 protein and MDR-1 P-glycoprotein expression 
in invasive breast cancer: A prognostic study. Int J Cancer, 
112, 286-94.
Leonard GD, Fojo T, Bates SE (2003). The role of ABC 
transporters in clinical practice. Oncologist, 8, 411-24.
Li X-Q, Li J, Shi S-B, et al (2008). Expression of MRP1, BCRP, 
LRP and ERCC1 as prognostic factors in non-small cell 
lung cancer patients receiving postoperative cisplatin-based 
chemotherapy. Int J Biological Markers, 24, 230-7.
Li Y, Yuan H, Yang K, et al (2010). The structure and functions 
of P-glycoprotein. Current Med Chem, 17, 786-800.
Li Z, Wan H, Shi Y, et al (2004). Personal experience with four 
kinds of chemical structure drawing software: review on 
chemdraw, chemwindow, ISIS/Draw, and chemsketch. J 
Chem Informat Computer Sci, 44, 1886-90.
Lopez D, Martinez-Luis S (2014). Marine natural products 
with P-glycoprotein inhibitor properties. Marine drugs, 
12, 525-46.
Praveen K, Yellamma K (2014). Insilco identification of suitable 
acetuylcholinesterase inhibitors from morinda citrifolia 
linn. with reference to alzheimer’s disease. Int J Pharm Sci 
Res, 5, 5474.
Rauf A, Khan R, Raza M, et al (2015a). Suppression of 
inflammatory response by chrysin, a flavone isolated from 
Asian Pacific Journal of Cancer Prevention, Vol 17, 2016 55
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.1.51
Reversal of Multidrug Resistance in Mouse Lymphoma Cells by Extract and Flavonoids from Pistacia integerrima
Potentilla evestita Th. Wolf. In silico predictive study on its 
mechanistic effect. Fitoterapia, 103, 129-35.
Rauf A, Saleem M, Uddin G, et al (2015b). Phosphodiesterase-1 
inhibitory activity of two flavonoids isolated from pistacia 
integerrima JL stewart Galls. Evidence-Based Complem 
Altern Med, 2015.
Rauf A, Uddin G, Khan H, et al (2015c). Anti-tumour-promoting 
and thermal-induced protein denaturation inhibitory 
activities of β-sitosterol and lupeol isolated from Diospyros 
lotus L. Natural Product Res, 1-3.
Robey RW, Polgar O, Deeken J, et al (2007). ABCG2: 
determining its relevance in clinical drug resistance. Cancer 
Metastasis Rev, 26, 39-57.
Sakamoto A, Matsumaru T, Yamamura N, et al (2013). 
Quantitative expression of human drug transporter 
proteins in lung tissues: analysis of regional, gender, and 
interindividual differences by liquid chromatography-
tandem mass spectrometry. J Pharmaceutical Sci, 102, 
3395-406.
Sarkadi B, Homolya L, Szakacs G, et al (2006). Human multidrug 
resistance ABCB and ABCG transporters: participation in 
a chemoimmunity defense system. Physiological Rev, 86, 
1179-236.
Szabo D, Molnar J (1997). The role of stereoselectivity of 
chemosensitizers in the reversal of multidrug resistance of 
mouse lymphoma cells. Anticancer Res, 18, 3039-44.
Szakacs G, Paterson JK, Ludwig JA, et al (2006). Targeting 
multidrug resistance in cancer. Nature Reviews Drug 
Discovery, 5, 219-34.
Trott O, Olson AJ (2010). Autodock vina: improving the speed 
and accuracy of docking with a new scoring function, 
efficient optimization, and multithreading. J Comput Chem, 
31, 455-61.
Uddin G, Rauf A, Al-Othman AM, et al (2012a). Pistagremic 
acid, a glucosidase inhibitor from Pistacia integerrima. 
Fitoterapia, 83, 1648-52.
Uddin G, Rauf A, Arfan M, et al (2012b). Pistagremic acid a new 
leishmanicidal triterpene isolated from Pistacia integerrima 
Stewart. J Enzyme Inhibit Med Chem, 27, 646-8.
Uddin G, Rauf A, Rehman T, et al (2011). Phytochemical 
screening of Pistacia chinensis var. integerrima. Middle-East 
J Sci Res, 7, 707-11.
Visualizer DS (2005). Accelrys software inc. Discovery Studio 
Visualizer, 2.
Wallace AC, Laskowski RA, Thornton JM (1995). LIGPLOT: 
a program to generate schematic diagrams of protein-ligand 
interactions. Protein Rngineer, 8, 127-34.
